Drug repurposing for the treatment of COVID-19

Coronavirus disease 2019 (COVID-19) remains prevalent worldwide since its onset was confirmed in Wuhan, China in 2019. Vaccines against the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have shown a preventive effect against the onset and severity of COVID-19, and so...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Yuri, Nishiyama, Kazuhiro, Nishimura, Akiyuki, Noda, Takamasa, Okabe, Kaori, Kusakabe, Takahiro, Kanda, Yasunari, Nishida, Motohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040495/
https://www.ncbi.nlm.nih.gov/pubmed/35641023
http://dx.doi.org/10.1016/j.jphs.2022.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040495/
https://www.ncbi.nlm.nih.gov/pubmed/35641023
http://dx.doi.org/10.1016/j.jphs.2022.04.007

Ejemplares similares